Last reviewed · How we verify
NCT06183424
TDCS Stimulation After Covid-19 Infection
NA trial testing Transcranial Direct Stimulation in COVID-19 in 50 participants. Currently enrolling.
1 October 2024
Quick facts
| Lead sponsor | Istanbul Medipol University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 October 2023 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Transcranial Direct Stimulation
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
Istanbul Medipol University Hospital
Who can join
Adults 18 to 50, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (memory and executive) functions in patients with Covid-19 infection and subjective cognitive complaints, as well as resting-state fMRI In the case of dfMRI, it is aimed to examine the default mode network (DMN) and parietal memory network (PMN) inter- and intra-network connectivity alterations and the hippocampal region connectivity alterations and contribute to the relevant literature.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06183424
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial Direct Stimulation
Trials testing the same drug.
- NCT04908631 — Safety and Feasibility of tDCS to Enhance Auditory Rehabilitation in Cochlear Implant Recipients · NA · completed
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Istanbul Medipol University Hospital trials
Trials by the same sponsor.
- NCT07508371 — Menthol Massage for Post-Bypass Pain & Anxiety · NA · not yet recruiting
- NCT07575477 — Comparison Of Early Mobilization And Electrical Stimulation On Functional Recovery After Lumbar Disc Herniation Surgery · NA · not yet recruiting
- NCT07525115 — Effects of Proprioceptive Neuromuscular Facilitation-Based Lower Extremity Training on Balance, Gait, and Functional Ind · NA · not yet recruiting
- NCT07467278 — Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome · NA · not yet recruiting
- NCT07468864 — Validity of the Turkish Situational Vertigo Questionnaire · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06183424 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medipol University Hospital
- Last refreshed: 2 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06183424.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing